Investing.com — Novo Nordisk A/S (NYSE:NVO) stock jumped nearly 8% in after-hours trading on Monday after the U.S. Food and Drug Administration approved the company’s Wegovy pill as the first oral …
Novo Nordisk stock soars after FDA approves first oral GLP-1 for weight loss
view original post